Lamotrigine Aurobindo

Lamotrigine, the active ingredient in Lamotrigine Aurobindo, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types and to stabilize mood in bipolar disorder, providing therapeutic benefit across neurological and psychiatric indications.

GNH USA supplies Lamotrigine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that acts on neuronal excitability and is indicated for several seizure‑related and mood‑stabilizing conditions. - Epilepsy: reduces the frequency and severity of generalized and focal seizures. - Bipolar disorder: helps prevent mood episodes, particularly depressive phases. - Seizure disorders: controls partial seizures with or without secondary generalisation.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Nausea: occasional gastrointestinal upset. - Rash: non‑specific skin irritation. - Insomnia: difficulty initiating sleep. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Aseptic meningitis: signs of meningitis without infection. - Blood dyscrasias: abnormal blood counts such as agranulocytosis. - Hepatic dysfunction: elevated liver enzymes. - Severe hypersensitivity: systemic allergic response. - Suicidal ideation: emergence of thoughts of self‑harm.

Lamotrigine requires careful monitoring and patient education to minimise risks. - Initiation: start at low dose and titrate slowly to reduce rash risk. - Pregnancy: safety category unknown; weigh benefits against potential fetal risk. - Breastfeeding: assess infant exposure versus maternal benefit. - Concomitant drugs: avoid strong enzyme inducers that may lower plasma levels. - Renal/hepatic impairment: adjust dosing if organ function is compromised. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising risk of severe rash. - Carbamazepine: reduces lamotrigine exposure, potentially compromising efficacy. - Phenobarbital: accelerates lamotrigine metabolism, lowering therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine concentrations, requiring dose adjustment. - Sertraline: modest increase in lamotrigine levels, monitor for side effects. - Phenytoin: may modestly reduce lamotrigine exposure. - Rifampin: induces metabolism, potentially lowering lamotrigine levels. - Topiramate: additive CNS effects, observe for dizziness or cognitive changes.